When will it be enough to convince policymakers to change course? Action Alert! A new study published in JAMA Pediatrics has linked fluoride exposure with lower IQ. This is the latest in a long line of studies demonstrating the dangers of water fluoridation, but policymakers are still refusing to act. The study found that women […]
The short answer: 5G networks, which are coming to your town. Action Alert! Recently we told you how telecom companies are working with the federal government to eliminate local control over the deployment of 5G networks, which are billed as the next best thing in wireless technology. Recent research pointing to the health implications of […]
More and more concerned citizens are asking tough questions about the safety of 5G wireless networks. Are big tech companies trying to quash their dissent? Action Alert! Over the last few months, we’ve been reporting on the planned deployment of 5G wireless networks and some of the health and safety issues that are being swept […]
More and more concerned citizens are asking tough questions about the safety of 5G wireless networks. Are big tech companies trying to quash their dissent? Action Alert! Over the last few months, we’ve been reporting on the planned deployment of 5G wireless networks and some of the health and safety issues that are being swept […]
Organic GMOs? Under Secretary of Agriculture Greg Ibach recently told a House Agricultural Subcommittee that it may be time to start having a conversation about whether technologies such as gene editing can be used to enhance organic production. It’s no surprise, really: we’ve been saying for years now that special interests are watering down organic […]
…by Big Pharma advertisers. “It is simply no longer possible to believe much of the clinical research that is published, or to rely on the judgment of trusted physicians or authoritative medical guidelines.” Those are the words of Dr. Marcia Angell, former editor-in-chief of the prestigious New England Journal of Medicine. She was discussing the […]
…that will cost $2.1 million. The Food and Drug Administration (FDA) recently approved a gene therapy drug for a form of spinal muscular atrophy (SMA). Novartis is pricing the drug, Zolgensma, at $2.125 million, or $425,000 per year for five years. The drug is meant to treat children under 2 years of age with SMA, […]
